Pfizer Inc annual operating income for fiscal TTM was $14.8 billion, a decrease of 3.8% from $15.4 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $14.8B | $15.4B | $16.5B | $5.3B | $37.5B | $20.8B | $9.1B | $7.5B | $15.3B | $14.4B | $14.3B | $13.3B | $14.0B | $16.9B | $18.0B | $18.4B | $17.7B | $16.0B | $16.6B | $13.9B | $15.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $4.0B | $3.7B | $3.5B | $3.6B | $4.6B | $5.7B | $5.0B | $1.9B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More PFE metrics: Revenue · Gross Profit · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All PFE financial statements → Interactive PFE charts →
About TickerBase · Data methodology & sources